The medical community is buzzing about the new drug, a combination therapy showing remarkable results in early studies . This new compound, a incretin receptor alongside a similar compound, appears to effectively decrease body mass and improve metabolic health . Researchers are suggesting that it has the potential to offer a valuable advance for in